A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells
Julie A. Vendrell(Inserm), Pascale A. Cohen(Lyon 1 Université), Charles Dumontet(Centre de Recherche en Cancérologie de Lyon), S Ben-Larbi(Inserm), Sandra E. Ghayad(Inserm), Nadir Mechti(Centre National de la Recherche Scientifique)
Cited by 92
Related Papers
Antibody–drug conjugates come of age in oncology
|Nature Reviews Drug Discovery|2023|772
Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)
|The Lancet Oncology|2014|410
Cracking the Estrogen Receptor's Posttranslational Code in Breast Tumors
|Endocrine Reviews|2011|302
Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach
|Endocrine Related Cancer|2006|239
Clinical practice guidelines for BRCA1 and BRCA2 genetic testing
|European Journal of Cancer|2021|174